Modification of the association between PM10 and lung function decline by cadherin 13 polymorphisms in the SAPALDIA cohort : a genome-wide interaction analysis by Imboden, Medea et al.
72 volume 123 | number 1 | January 2015 • Environmental Health Perspectives
Research A Section 508–conformant HTML version of this article is available at http://dx.doi.org/10.1289/ehp.1307398. 
Introduction
Lung function is a complex phenotype 
 influenced by lifestyle, environmental, and 
genetic factors. Inverse associations between 
chronic exposure to air pollution, such as 
particulate matter (PM), and respiratory 
function level as well as its decline have been 
reported in independent settings (Downs 
et al. 2007; Katanoda et al. 2011; Romieu 
et al. 2009; Schikowski et al. 2010). Air 
pollutants are thought to mediate their acute 
and chronic effects through an increase in 
oxidative stress, inflammation, and cyto-
toxicity (Andreau et al. 2012; Huang et al. 
2012). However, mechanisms and differences 
in susceptibility remain poorly characterized 
(Brook et al. 2010). Only few candidate 
gene–air pollution inter action studies have 
been published. These reports also point to 
the oxidative and inflammatory effects of air 
pollution in mediating adverse respiratory 
health effects (Breton et al. 2011; Curjuric 
et al. 2012; Imboden et al. 2009; Melén et al. 
2008; Romieu et al. 2006; Yang et al. 2005).
Genome-wide associat ion s tudies 
(GWAS) on lung function were mostly 
cross-sectional in nature (Artigas et al. 2011; 
Hancock et al. 2010, 2012; Obeidat et al. 
2011; Repapi et al. 2010; Wilk et al. 2009), 
and more recent reports have shown that the 
overlap in genetic determinants of the level 
of lung function and its decline is minimal 
(Hansel et al. 2013; Imboden et al. 2012). 
None of these lung function GWAS studies 
has considered ambient air pollution.
In the present study, we used a genome-
wide inter action study (GWIS) approach 
to uncover novel genetic loci modifying 
the association between particulate matter 
exposure and 11-year lung function decline. 
We applied a two-stage approach with a 
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Background: Both air pollution and genetic variation have been shown to affect lung function. 
Their inter action has not been studied on a genome-wide scale to date.
oBjectives: We aimed to identify, in an agnostic fashion, genes that modify the association 
between long-term air pollution exposure and annual lung function decline in an adult population-
based sample.
Methods: A two-stage genome-wide inter action study was performed. The discovery (n = 763) 
and replication (n = 3,896) samples were derived from the multi-center SAPALDIA cohort 
(Swiss Cohort Study on Air Pollution and Lung Disease in Adults). Annual rate of decline in the 
forced mid-expiratory flow (FEF25–75%) was the main end point. Multivariate linear regression 
analyses were used to identify potential multiplicative inter actions between genotypes and 11-year 
cum ulative PM10 exposure.
results: We identified a cluster of variants intronic to the CDH13 gene as the only locus with 
genome-wide significant inter actions. The strongest inter action was observed for rs2325934 
(p = 8.8 × 10–10). Replication of the inter action between this CDH13 variant and cumulative 
PM10 exposure on annual decline in FEF25–75% was successful (p = 0.008). The inter action was not 
sensitive to adjustment for smoking or body weight.
conclusions: CDH13 is functionally linked to the adipokine adiponectin, an inflammatory 
regulator. Future studies need to confirm the inter action and assess how the result relates to 
previously observed inter actions between air pollution and obesity on respiratory function.
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discovery sample (n = 763) and a replication 
sample (n = 3,896). Both are subpopula-
tions of the SAPALDIA cohort study (Swiss 
Cohort Study on Air Pollution And Lung 
Diseases In Adults) (Martin et al. 1997). This 
multi-center population-based cohort was 
specifically designed to investigate long-term 
effects of air pollution on respiratory health. 
We a priori chose forced mid-expiratory flow 
(FEF25–75%) as the dependant lung function 
phenotype because it was the outcome most 
strongly associated with ambient particulate 
matter air pollution exposure in SAPALDIA 
(Downs et al. 2007). As a proxy for long-term 
exposure to complex air pollution mixtures, 
we chose personal estimates of 11-year 
cumulative exposure to home outdoor PM 
mass with ≤ 10 μm in aerodynamic diameter 
(PM10) (Curjuric et al. 2012; Liu et al. 2007).
Methods
SAPALDIA cohort study. SAPALDIA was 
initiated in 1991. Participants, 18–60 years 
of age, were randomly selected from the 
population registries of eight geographic Swiss 
regions, with varying degrees of urbanization 
and different environmental and cultural 
characteristics. Participants of the baseline 
examination (n = 9,651) were invited in 
2002 (n = 8,047) for a second examination. 
Ethical approval was obtained from the Swiss 
Academy of Medical Sciences and the Regional 
Ethics Committees; written informed consent 
was obtained from all participants before 
health examination and biological sample 
collection at each survey. Study design and 
data collected have been described elsewhere 
(Ackermann-Liebrich et al. 2005). Briefly, 
health examinations and standardized ques-
tionnaires focused on respiratory and cardio-
vascular health. Formal collection of fractioned 
blood and DNA samples was established at the 
follow-up survey.
Study population. Nonparticipation 
at follow-up (n = 1,604) and missing infor-
mation on lung function phenotype data 
(n = 2,302), genotype data (n = 476), or 
covariates (n = 43) led to the exclusion of 
some SAPALDIA cohort participants from the 
present study. Participants reporting a history 
of asthma were excluded (n = 567) because 
of evidence of genetic heterogeneity of lung 
function decline in asthmatic and nonasth-
matic subjects (Imboden et al. 2012). The 
final study population included participants 
with blood samples available for genetic testing 
and complete baseline and follow-up data on 
spirometry, smoking history, weight, weight 
change, height, PM10 exposure, and residential 
history, as well as statistical model covariates 
(n = 4,659) (Downs et al. 2007). The discovery 
sample with genome-wide data was a random 
sample of the nonasthmatic SAPALDIA study 
population (n = 763) (Moffatt et al. 2010). 
The replication sample consisted of the 
remainder of SAPALDIA participants with 
complete data (n = 3,896) and was subjected 
to targeted genotyping for replication of 
 promising discovery inter action signals.
Phenotype and covariate assessment. For 
lung function assessment, identical spirom-
eter devices (Sensormedics model 2200; 
Sensormedics, Yorba Linda, CA, USA) 
and protocols were used at both examina-
tions (Ackermann-Liebrich et al. 2005). 
Comparability of devices was ascertained 
(Künzli et al. 2005). Each participant 
performed three to a maximum of eight 
forced expiratory lung function maneuvers 
to obtain a minimum of two acceptable 
forced expiratory flows, forced vital capacity 
(FVC), forced expiratory volume in the first 
second (FEV1) complying with American 
Thoracic Society (1995) criteria. Expiratory 
flow measures during the middle half of 
the FVC (FEF25–75%) were taken from the 
flow-volume curves with the highest sum 
of FVC and FEV1. Given evidence from 
the SAPALDIA cohort, we focused in the 
present study on the annual rate of decline in 
FEF25–75% as a sensitive marker of age-related 
decline because it was more strongly associ-
ated with the PM10 exposure than was FEV1 
or FEV1/FVC decline (Curjuric et al. 2010; 
Downs et al. 2007; Imboden et al. 2009; Thun 
et al. 2012). Annual decline in FEF25–75% was 
calculated as the difference between follow-up 
and baseline measure in milliters per second, 
divided by length of follow-up in years. 
Accordingly, declines in FEV1, FEV1/FVC, 
and FEF25–75%/FVC were calculated for 
sensitivity analyses of the FEF25–75% GWIS 
top hits. Covariate information was assessed 
including a computer-assisted personal inter-
view at baseline and follow-up examinations, 
including age, sex, current and past smoking 
status, and smoking history (number of ciga-
rettes/day, years of smoking). The exposure to 
other inhaled pollutants such as environmental 
tobacco smoke or occupational exposure to 
dust and fumes, and respiratory symptoms 
were assessed with the same questions at both 
surveys. Participants who reported smoking 
< 20 packs of cigarettes and < 360 g of tobacco 
in their lifetime at both time points were 
defined as never-smokers. Cumulative cigarette 
exposure of participants was assessed by pack-
years smoked before the first examination and 
pack-years smoked during follow-up. Height 
was measured (without shoes) at baseline and 
follow-up. Weight was self-reported at baseline 
and measured at follow-up (without shoes and 
coat). Weight change was calculated as weight 
at follow-up minus weight at baseline, with 
positive values reflecting weight gain during 
follow-up period.
Home outdoor PM10 exposure assessment. 
We used PM10 as the air pollution exposure 
measure. Air pollution exposure assessment, 
dispersion model validation, as well as attribu-
tion of individual 11-year cumulative PM10 
exposure have been described elsewhere (Liu 
et al. 2007). Briefly, a hybrid exposure model 
incorporated geocoded data on seasonal, 
meteoro logical, and traffic, industrial, 
regional, and agricultural emission activities. 
Hourly concentrations of PM10 were calcu-
lated on a spatial resolution of 200 × 200 m 
grid cells over the follow-up period. Annual 
averages of the modeled PM10 concentrations 
were obtained for each grid cell. We estimated 
the cumulative PM10 exposure for study 
participants using their residential history, in 
geocoded data format, assigning annual PM10 
exposure averages derived from the grid cells 
generated by the dispersion model, and adding 
up the averages over the 11-year follow-up 
period (Liu et al. 2007).
Genotyping, imputation, population 
stratification, and quality control. DNA 
extraction from EDTA-buffered whole blood 
has been previously described (Ackermann-
Liebrich et al. 2005; Imboden et al. 2006). 
Genome-wide genotyping was obtained using 
the platform Illumina 610K quad Bead Chip. 
Discovery genotyping quality control, impu-
tation, and correction for population strati-
fication was applied as previously described 
(Moffatt et al. 2010). Briefly, genome-wide 
genotyping was centrally performed for the 
GABRIEL asthma Consortium at the Centre 
National de Génotypage (CNG, Evry, 
France). We satisfactorily genotyped 567,589 
autosomal single nucleotide polymorphisms 
(SNPs) (mean call rate, 99.7%). We obtained 
2,588,592 autosomal HapMap-based SNPs by 
cohort-specific imputation using the MACH 
v1.00 software and the HapMap2 release 22 
CEU reference sample (Moffatt et al. 2010). 
Statistical power to detect gene–environment 
inter action is expected to be limited, so we 
excluded SNPs with minor allele frequen-
cies < 5% to avoid inflation of false positive 
findings produced by rare genetic variants. 
Final number of SNPs used for inter action 
association testing was 2,198,793. To account 
for population stratification, we relied on 
inferred ancestry-informative principal compo-
nents (Moffatt et al. 2010) that were previ-
ously carried out using EIGENSTRAT 2.0 
software and the all ethnicity HapMap data, as 
well as additional European reference samples 
(Heath et al. 2008). Subjects of non-European 
descent were excluded based on the first and 
second principal components. Adjustment for 
population stratification in the linear regression 
analyses was done by incorporating the third 
and fourth principal component in the statis-
tical model. Cryptic relatedness was detected 
based on identity-by-state analysis, and one 
participant per family cluster was retained in 
the study population.
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Statistical analysis. Discovery sample. 
We performed agnostic GWIS analysis in the 
discovery sample using an additive genetic 
model, with a priori selection of potential 
confounders based on previous analyses of 
the association between air pollution and 
lung function decline (Curjuric et al. 2010; 
Downs et al. 2007; Imboden et al. 2009). We 
regressed each SNP with cumulative PM10 
on FEF25–75% annual decline adjusting for 
study center, age, sex, height, never-smoking 
status, seasonal effects (sine and cosine 
function of day of examination), and popula-
tion stratification factors. In addition, models 
were adjusted for weight at baseline, weight 
change during follow-up, and the multiplica-
tive inter action between baseline weight and 
weight change, based on our recent analysis 
demonstrating an inter action between air 
pollution and obesity on lung function in the 
study population (Schikowski et al. 2013). 
Potential inter action effects between genotype 
and PM10 were captured by the inclusion of 
a multiplicative inter action term in the linear 
multivariate regression analyses. We used 
a joint test with two degrees of freedom to 
derive p-values for the joint effects of gene 
marginal and gene–environment inter actions. 
This approach has been shown under a range 
of scenarios to have greater power for iden-
tifying novel genetic candidates than tests of 
the gene marginal effect or gene– environment 
inter action effects alone (Hancock et al. 2012; 
Kraft et al. 2007). We used the following 
terminology to report the results of the genetic 
effects related to the gene marginal (pmain), 
the gene–environment (pint), and the joint 
(pjoint) effects referring to their respective null 
hypothesis of gene marginal (βmain = 0), the 
gene–environment (βint = 0), and the joint 
(βmain = 0 and βint = 0) effects. We defined 
the genome-wide significance level at 
p < 5 × 10–8 using Bonferroni adjustment for 
one million independent tests. The lambda 
(λ) for the main GWIS—a metric for esti-
mating genomic inflation of the observed 
associations—was calculated as the ratio of the 
observed versus expected median of the chi-
square distribution with 2 degrees of freedom 
[ΣChi2(2df); medianobserved divided by 1.386 
(medianexpected)]. GWIS sensitivity analyses 
were additionally performed on FEV1, 
FEV1/FVC, and FEF25–75%/FVC decline to 
determine the genome-wide ranking of the 
FEF25–75% top hits in the GWIS results for 
other lung function phenotypes.
Replication sample. The replication 
analyses was performed on two intronic 
CDH13 SNPs exhibiting the lowest or very 
low p-values in the discovery phase without 
being in high linkage disequilibrium with one 
other (top hit, rs232593, and rs17284098). 
Replication de novo genotyping of rs2325934 
and rs17284098 was performed on a 7900HT 
Fast Real-Time PCR System (Applied 
Biosystems, Foster City, CA, USA) by using 
5´-nuclease allelic discrimination assays. A 
random sample of approximately 10% of all 
DNA samples was re-genotyped, and all geno-
types were confirmed. The genotype call rate 
was > 99%. The same adjustments as for the 
discovery GWIS were used, except that adjust-
ment for population stratification was not 
possible in the replication sample. We do not, 
however, expect associations to be confounded 
in the replication sample because adjustment 
for population stratification did not influence 
associations in the discovery sample (data not 
shown). Given the gene– environment inter-
action identified, we performed genotype 
stratified analyses in the combined sample 
(discovery and replication) as well as addi-
tional explorative analyses assessing the 
robustness of the observed PM10–CDH13 
inter action with a particular focus on smoking 
and on weight-related variables.
Post hoc analysis on CDH13. In a 
post hoc analysis, we first searched the 
dbGaP database (http://www.ncbi.nlm.nih.
gov/projects/gapplusprev/sgap_plus.htm) 
for reported associations of CDH13 genetic 
variants using “CDH13” as the search term 
and looked up the GWIS result of these 
SNPs for inter action with PM10 on decline 
in FEF25–75%. Second, we used the imputed 
data obtained in the SAPALDIA discovery 
sample to construct haplotypes in a 200-kb 
chromosomal window centered on the GWIS 
top hit using the software Haploview (Barrett 
et al. 2005). Third, based on the strong func-
tional link between CDH13 and adiponectin, 
we looked up the GWIS result of SNPs in 
the ADIPOQ gene, the adiponectin precursor 
protein, for inter action with PM10 on decline 
in FEF25–75% and made a regional association 
plot of the ADIPOQ locus using the software 
LocusZoom (Pruim et al. 2010).
Results
Baseline characteristics of the SAPALDIA 
cohort study participants included in the 
current GWIS analysis of the discovery and 
replication sample are presented in Table 1. 
We observed a highly comparable distribu-
tion of sex, age, baseline body mass index, 
weight change during follow-up, baseline lung 
function level, and average PM10 exposure 
at baseline and during follow-up, except for 
a small difference in proportion in smokers 
and smoking intensity between the two 
samples (Table 1).
GWIS discovery results. We observed 
significant association signals with a group of 
13 SNPs, interacting with cumulative PM10 
exposure on annual decline in FEF25–75%, at 
a single locus on chromosome 16 (Figure 1A). 
The quantile–quantile plot of inter action 
p-values showed evidence for a higher number 
of significant signals than expected by chance 
(Figure 1B). Based on the lambda observed 
(λ = 1.0476), adequate genomic control of the 
genome-wide associations had been applied.
The association signal at 16q23.3, located 
intronic to gene CDH13 (Table 2), had the 
strongest inter action (pint = 8.8 × 10–10) for 
rs2325934, an uncommon variant [MAF 
(frequency of the least common allele in the 
study sample), 9.6%]. There was evidence 
for additional potentially independent inter-
action signals in this locus, as variants with 
varying MAFs and differing linkage disequi-
librium (LD) values also showed significant 
Table 1. Baseline characteristics of the study population of the SAPALDIA cohort, discovery and replication 
sample (mean ± SD or %).
Characteristic Discovery Replication
n 763 3,896
Female (%) 51.1 51.6
Age (years) 41.6 ± 11.0 41.1 ± 11.4
Body mass index (kg/m2) 23.5 ± 3.5 23.7 ± 3.6
Height (cm) 169.6 ± 9.0 169.5 ± 8.7
Weight (kg) 67.9 ± 12.6 68.4 ± 12.6
Weight changea (kg) 5.4 ± 6.2 5.6 ± 6.0
Baseline lung function
FEF25–75% (L/sec) 3.5 ± 1.2 3.5 ± 1.2
FEV1 (L) 3.6 ± 0.8 3.6 ± 0.8
FEV1/FVC (%) 79.6 ± 7.0 79.4 ± 7.2
FEF25–75%/FVC (%) 78.1 ± 24.5 77.6 ± 24.7
Air pollution exposure
PM10 annual mean (μg/m3) 27.4 ± 9.4 27.3 ± 9.7
PM10 cumulativea (μg/m3) 246.5 ± 79.0 245.2 ± 81.4
Smoking status
Never-smokersb (%) 42.9 43.8
Pack-yearsc 16.5 ± 17.3 17.0 ± 18.2
Pack-yearsa,c 5.4 ± 6.5 6.3 ± 8.3
Abbreviations: FEF25–75%, forced mid-expiratory flow; FEF25–75%/FVC, ratio of forced mid-expiratory flow and of forced 
vital capacity; FEV1, forced expiratory volume in the first second; FEV1/FVC, ratio of forced expiratory volume in the first 
second and of forced vital capacity; FVC, forced vital capacity. 
aDuring 11-year follow-up. bNever-smokers defined as nonsmoker at baseline and at follow-up survey. cDiscovery 
sample: missing data on pack-years at baseline (n = 20, 2.6%) and during follow-up (n = 62, 7.3%); replication sample: 
missing data on pack-years at baseline (n = 67, 1.7%) and during follow-up (n = 326, 8.4%). 
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inter actions with cumulative PM10 on 
annual FEF25–75% decline (e.g., rs11643197: 
MAF, 13.4%, pint = 6.87 × 10–8, LD with 
the CDH13 top hit rs2325934 r2 = 0.585 
and D´ = 1) (Figure 2; see also Supplemental 
Material, Figure S1). p-Values for gene 
main effects (pmain), gene–environment 
inter action effects (pint), and the joint test 
(pjoint) are provided in Table 2 for intronic 
CHD13  SNPs,  and in Supplemental 
Material, Table S1, for the top 1,000 SNPs 
associated with the decline in FEF25–75% 
in the discovery GWIS, ranked by gene– 
environment inter action effects (pint). The 
joint test of the SNP main effect and the 
inter action effect (pjoint, null hypothesis: 
βmain = 0 and βint = 0) did not identify addi-
tional genetic modifiers of the association 
between cumulative PM10 and lung function 
decline beyond those already identified based 
on pint for the gene–environment inter-
action, and the CDH13 variants ranked high 
according to gene main effect, inter action, 
and joint tests (maximum genome-wide 
rank = 22 for the joint test; Table 2).
Next, we performed sensitivity GWIS 
analyses for annual decline in FEV1, in 
FEV1/FVC, and in FEF25–75%/FVC to assess 
the ranking of the CDH13 variants (see 
Supplemental Material, Table S2). Briefly, 
although genome-wide significance was not 
reached, the CDH13 locus was the top-ranking 
locus in the GWIS for decline in ratios of both 
FEV1/FVC and FEF25–75%/FVC, but it was 
not strongly associated with annual decline 
in FEV1 (pint ≥ 0.001). For FEV1/FVC and 
FEF25–75%/FVC, the CDH13 SNP with the 
strongest inter action p-value was rs2325934 
(for FEV1/FVC: pint = 1.99 × 10–6; for 
FEF25–75%/FVC: pint = 1.47 × 10–6).
GWIS replication results. We selected two 
genome-wide significant CDH13 SNPs for 
Table 2. Discovery GWIS top hits with p-values for interaction (pint) < 10–7, clustered intronically to the CDH13 gene: adjusted interaction association with 
 individualized cumulative PM10 exposure on annual decline in FEF25–75% in the SAPALDIA cohort. 









Genome-wide test rank Strong LD 
groupsaMain Interaction Joint
rs2325934b 16 81900000 9.64 6.94 × 10–11 8.80 × 10–10 5.80 × 10–10 1 1 1 Reference (A)
rs17282232 16 81905824 11.12 5.26 × 10–9 7.28 × 10–8 3.64 × 10–8 13 17 13 Reference (B)
rs10514582 16 81910432 8.66 3.71 × 10–9 3.93 × 10–8 2.72 × 10–8 11 12 11 A
rs10514580 16 81910872 9.71 1.89 × 10–10 4.10 × 10–9 1.47 × 10–9 4 7 4 A
rs16960234 16 81913512 9.95 9.90 × 10–11 1.82 × 10–9 8.05 × 10–10 2 3 2 A
rs12325503 16 81917248 11.21 5.98 × 10–9 6.23 × 10–8 4.30 × 10–8 14 15 14 B
rs10514578 16 81917312 11.20 6.01 × 10–9 6.07 × 10–8 4.34 × 10–8 15 14 15 B
rs17210599 16 81918568 9.93 1.18 × 10–10 1.49 × 10–9 9.77 × 10–10 3 2 3 A
rs10514575 16 81931320 9.85 3.95 × 10–10 2.61 × 10–9 3.12 × 10–9 5 4 5 A
rs17211371 16 81933040 9.98 7.20 × 10–10 4.03 × 10–9 5.56 × 10–9 6 6 6 A
rs1424168 16 81935600 10.10 1.36 × 10–9 6.95 × 10–9 1.03 × 10–8 7 9 7 A
rs17211581 16 81937240 10.11 1.44 × 10–9 7.40 × 10–9 1.09 × 10–8 8 10 9 A
rs17284098b 16 81947576 12.87 1.56 × 10–8 3.98 × 10–8 1.02 × 10–7 16 13 16 Reference (C)
rs17284265 16 81949792 12.14 5.13 × 10–9 1.57 × 10–8 3.55 × 10–8 12 11 12 C
rs17284390 16 81954784 11.90 2.01 × 10–9 5.08 × 10–9 1.33 × 10–8 10 8 10 C
rs17212165 16 81955688 11.96 1.71 × 10–9 3.30 × 10–9 1.05 × 10–8 9 5 8 C
rs11643197 16 81964792 13.36 6.35 × 10–8 6.87 × 10–8 3.17 × 10–7 17 16 22 C
Ranks shown in the table refer to the genome-wide ranking over 2,198,793 SNPs. The following terminology defined genetic effects referring to their respective null hypothesis: pmain: 
gene marginal (βmain = 0); pint: gene–environment (βint = 0); pjoint: joint effect (βmain = 0 and βint = 0). GWIS was adjusted for study center, age, sex, height, never-smoking status, weight 
at baseline, weight change during follow-up, interaction between baseline weight and weight change, seasonal effects of time point of baseline and follow-up examination date (sine 
and cosine function of day of examination) and population stratification components. Cohort participants with self-report of asthma history had been excluded from the analysis. 
Discovery sample size was n = 763.
aLD (linkage disequilibrium): A indicates strong LD with rs2325934 (r2 > 0.85; D´ = 1), B indicates strong LD with rs17282232 (r 2 > 0.85; D´ = 1), and C indicates strong LD with rs17284098 
(r2 > 0.85; D´ = 1). The replication SNPs, rs2325934 and rs17284098, were in the moderate linkage disequilibrium with each other (r2 = 0.685, D´ = 1). bSNPs selected for replication; they 
were in the moderate linkage disequilibrium with respect to r 2 (r 2 = 0.685, D´ = 1). 
Figure 1. Genome-wide interactions between cumulative PM10 exposure on annual decline in FEF25–75% in the discovery sample (n = 763) of the SAPALDIA cohort 
study. (A) Manhattan plot of the negative log of the p-values (pint) of 2,198,793 SNPs used for interaction association testing. CDH13 SNP cluster with interaction 
p-values reaching genome-wide significance are above the line and SNPs in the CDH13 locus are highlighted in green. (B) Quantile–quantile plot representing 
calculated p-values (pint) for each PM10 by SNP interaction tested plotted against the expected chi-square–distributed p-values. Deviation from the diagonal 
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de novo genotyping in the replication study 
sample (n = 3,896). The rs2325934 variant 
was selected because it exhibited the lowest 
p-value of association (pint) in the discovery 
analysis. A second SNP, rs17284098 (MAF, 
12.9%; discovery pint = 3.98 × 10–8) was 
chosen for its higher MAF compared with 
the top hit. Both replication SNPs were 
in moderate LD (r2 = 0.685 and D´ = 1). 
They replicated yielding p-values below the 
Bonferroni corrected significance level for 
two tests (p < 0.025; rs2325934: pint = 0.008; 
rs17284098: p int = 0.016; Table 3). 
Interactions between the CDH13 replication 
SNPs and PM10 were robust to adjustment 
for different covariates (Table 3). The observed 
association became slightly stronger despite 
diminished sample size (n = 3,504) when 
adjusted for history of smoking intensity, 
including pack-years at baseline and pack-years 
smoked during follow-up. However, it is not 
possible to determine whether the change was 
attributable to adjustment or to a difference 
in the sample. Omitting smoking adjustment 
resulted in weakened signal, as did omitting 
the inter action term between weight and 
weight change. In contrast, adjusting addition-
ally for age-squared slightly strengthened the 
associations. The PM10 effect modification by 
the CDH13 SNPs remained significant even in 
minimally adjusted (age, sex, and study area) 
models (rs2325934: pint = 0.019; rs17284098: 
pint = 0.020; Table 3).
In a genotype-stratified analysis, combining 
discovery and replication sample, for both 
CDH13 SNPs, the PM10–FEF25–75% asso-
ciation appeared to be restricted to partici-
pants who were homozygous for the major 
allele (see Supplemental Material, Table S3). 
For rs2325934, the major homozygous 
genotype strata (n = 3,750) was estimated to 
have an average annual change in FEF25–75% 
of –0.102 mL per increase of 1 μg/m3 PM10 
[95% confidence interval (CI): –0.19, –0.01; 
p = 0.03] in contrast with the group carrying at 
least one minor allele (estimated average annual 
change of 0.074 mL; 95% CI: –0.16, 0.31; 
p = 0.53, n = 886).
Previously published CDH13 genome-
wide association results  and linkage 
 disequilibrium in the 200-kb GWIS window. 
In GWAS, variants of the CDH13 gene 
were previously associated with a number 
of different phenotypes (see Supplemental 
Material, Table S4). Genetic variants in the 5´ 
end of the CDH13 gene have been repeatedly 
associated with circulating adiponectin levels 
(Chung et al. 2011; Dastani et al. 2012; Jee 
et al. 2010; Morisaki et al. 2012; Wu et al. 
2010). We thus looked up the inter actions 
of these previous CDH13 GWAS hits with 
PM10 on decline in FEF25–75%, but none of 
these SNPs ranked high in the current GWIS 
(pint ≥ 0.02; see Supplemental Material, 
Table S4). Pairwise LD in the CDH13 gene 
between the GWAS SNPs and the PM10 
interacting SNPs was low (r2 ≤ 0.33).
The structure of linkage disequilibrium 
(see Supplemental Material, Figure S1) and 
haplotypes (see Supplemental Material, 
Figure S2) in the 200-kb window centered on 
rs2325934 were constructed using the imputed 
genotype data of the discovery sample. The 
LD pattern and derived haplotypes suggested 
that the GWIS top hit tagged specifically one 
33 kb–long haplotype (block 9, stretching 
from rs2352934 to rs1426166). The second 
replication variant, rs17284098, was located 
in a different 11 kb–long haplotype (block 11, 
stretching from rs1424168 to rs17284098) in 
an intron downstream of the GWIS top hit.
Discussion
To our knowledge, this is the first report 
presenting a genome-wide inter action study 
aiming to identify novel genes modifying the 
association of PM on lung function decline. 
We identified a cluster of SNPs intronic to 
the gene CDH13 that modified the estimated 
effect of cumulative PM10 on the decline 
in FEF25–75% in our study population. We 
estimated that participants who were homo-
zygous for the major allele of rs2325934 
experienced an excess average decline of 
11 mL/sec in FEF25–75% per 10-μg/m3 
increase in cumulative PM10 exposure over 
11 years. Interestingly, cadherin 13, the 
protein encoded by CDH13 is function-
ally linked to adiponectin, a predominantly 
anti-inflammatory adipokine.
Experimental animal studies have 
provided strong evidence that major cellular 
responses to PM exposure include oxida-
tive stress (Manzo et al. 2012) and inflam-
mation (Uski et al. 2012). Results from 
125 subjects monitored before, during, and 
after the Beijing Olympics were consistent 
with oxidative and inflammatory effects of 
Figure 2. Regional association plot showing the p-values of interaction between cumulative PM10 
exposure and CDH13 SNPs on annual decline in FEF25–75% in the discovery sample (n = 763) of the 
SAPALDIA cohort study. Shown is the regional association plot for the genome-wide significant GWIS 
association signal located in the CDH13 gene at 16q23.3. Negative log of the p-values are plotted on the 
y-axis. Genomic coordinates (Mb) of the plotted SNPs refer to genome build 36/hg18 and dbSNP128 and 
are given on the x-axis. Linkage disequilibrium information (r2 values) refers to HapMap Phase II data of 
Caucasian samples. Recombination rate shown over this chromosomal window indicates recombination 
sites as vertical lines. The plot was generated using LocusZoom (Pruim et al. 2010). Genes in the genomic 
vicinity are HSBP1, heat-shock factor-binding protein 1; MBTPS1, membrane-bound transcription factor 
protease, site 1; MIR3182, microRNA 3182; MLYCD, malonyl-CoA decarboxylase; NECAB2, N-terminal 
EF-hand calcium binding protein 2; OSGIN1, oxidative stress-induced growth inhibitor 1; SLC38A8, solute 
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ambient air pollution in the respiratory 
tract (Huang et al. 2012). The relationship 
between PM exposure and systemic inflam-
mation, as indicated by serum C-reactive 
protein (CRP), was the subject of a recent 
systematic review reporting more consistent 
results for a positive PM–CRP association in 
longitudinal studies of healthy subjects than 
in short-term studies or longitudinal studies of 
subjects with chronic inflammatory conditions 
(Li et al. 2012). The few candidate gene–air 
pollution inter action studies published to date 
also support the oxidative and inflammatory 
effects of air pollution in mediating adverse 
respiratory health effects (Breton et al. 2011; 
Curjuric et al. 2010; Imboden et al. 2009; 
Melén et al. 2008; Romieu et al. 2006; Yang 
et al. 2005).
In humans, CDH13 is expressed in various 
lung cell types, including bronchial epithelium 
and airway smooth muscle cells. The CDH13 
gene, spanning 1.17 Mb, encodes 15 different 
transcripts with alternate exons that produce 
structural proteins, which are expressed in 
endothelia, epithelia (including bronchial 
epithelial cells), smooth muscle cells, and in 
nervous tissue. The major CDH13 transcript 
contains 14 exons (Figure 3), encoding an open 
reading frame for a 713-amino acid polypep-
tide, cadherin 13, also known as T-cadherin, 
H-cadherin, or vascular adiponectin receptor. 
Previous GWAS have indicated that CDH13 
genetic variants may contribute to various 
phenotypes. The predicted molecular and 
cellular functions of cadherin 13 are congruent 
with some of the GWAS findings. The stron-
gest and most consistent GWAS signals have 
been SNPs in the 5´ untranslated region or in 
intron 1 associated with circulating adiponectin 
levels, consistent with the molecular function of 
adiponectin binding (GO:0055100) (Chung 
et al. 2011; Dastani et al. 2012; Jee et al. 2010; 
Morisaki et al. 2012; Wu et al. 2010). CDH13 
SNPs have also been reported to be associated 
with body height (Okada et al. 2010) and with 
respiratory function (http://www.ncbi.nlm.nih.
gov/projects/gapplusprev/sgap_plus.htm).
Cadherin 13 is one type of adiponectin-
binding protein (Hug et al. 2004), among 
others such as adiponectin receptors 
(AdipoR1, AdipoR2) (Yamauchi et al. 2003) 
or calreticulin (Takemura et al. 2007), and 
might exert its role in respiratory health 
through adiponectin. Adiponectin—a 244 
amino acid protein resembling collagen VII, 
X, and complement factor C1—has been 
identified as a potent and pleiotropic regu-
lator of inflammation (Ohashi et al. 2012). 
Experimental evidence in mice demonstrated 
Table 3. Replication results of adjusteda interaction of CDH13 intronic SNPs (rs2325934 and rs17284098) 
with cumulative PM10 during 11-year follow-up on annual decline in FEF25–75%, the SAPALDIA cohort 
study.
dbSNP ID n Coefficientb (95% CI) SE pint
Adjusted modela
rs2325934 3,879 0.0742 (0.0191, 0.1294) 0.0281 0.008
rs17284098 3,878 0.0632 (0.0117, 0.1147) 0.0263 0.016
Adjusted + smoking historyc
rs2325934 3,504 0.0766 (0.0198, 0.1335) 0.029 0.008
rs17284098 3,504 0.0723 (0.0188, 0.1257) 0.0273 0.008
Adjusted + age-squaredc
rs2325934 3,879 0.0755 (0.0205, 0.1306) 0.0281 0.007
rs17284098 3,878 0.0645 (0.0130, 0.1160) 0.0263 0.014
Adjusted: smoking statusd
rs2325934 3,879 0.074 (0.0188, 0.1291) 0.0281 0.009
rs17284098 3,878 0.0632 (0.0118, 0.1147) 0.0262 0.016
Adjusted: interaction between baseline weight 
and weight changed
rs2325934 3,879 0.0742 (0.0191, 0.1293) 0.0281 0.008
rs17284098 3,878 0.0629 (0.0114, 0.1144) 0.0263 0.017
Adjusted: weight change and interaction 
between baseline weight and weight changed
rs2325934 3,879 0.0757 (0.0212, 0.1301) 0.0278 0.006
rs17284098 3,878 0.0626 (0.0116, 0.1136) 0.026 0.016
Adjusted: weight at baseline and interaction 
between baseline weight and weight changed
rs2325934 3,879 0.0766 (0.0211, 0.1320) 0.0283 0.007
rs17284098 3,878 0.0657 (0.0141, 0.1173) 0.0263 0.013
Minimal adjustmente
rs2325934 3,879 0.0659 (0.0108, 0.1211) 0.0282 0.019
rs17284098 3,878 0.0606 (0.0095, 0.1117) 0.0261 0.02
aSame adjustments applied as for discovery GWIS, including study center, age, sex, height, never-smoking status, 
weight at baseline, weight change during follow-up, interaction between baseline weight and weight change, seasonal 
effects of time point of baseline and follow-up examination date (sine and cosine function of day of examination). No 
adjustment for population stratification was available. bCoefficient refers to the additive SNP effect in annual change 
in FEF25–75% (mL/sec) per 1-μg/m3 change in PM10 exposure. cSame adjustments as for the discovery GWIS, adding 
indicated additional covariate(s) in the model. dSame adjustments as for the discovery GWIS, omitting indicated 
covariate(s) in the model. eBasic adjustment including only study center, age, and sex in the model.
Figure 3. Schematic representation of CDH13 gene and genetic variants identified by GWAS to be associated with various phenotypes. The CDH13 gene, 
spanning 1.17 Mb, at 82.6 Mb (build 36) on chromosome 16, encodes 15 different transcripts with alternate exons which produce structural proteins. The major 
CDH13 transcript contains 14 exons, encoding an open reading frame for a 713-amino acid polypeptide. In this schematic view of the CDH13 gene, we pinpoint 
SNPs identified in the dbGaP database (http://www.ncbi.nlm.nih.gov/projects/gapplusprev/sgap_plus.htm) for reported associations with various phenotypes 
using “CDH13” as the search term. For a list of the  associated phenotypes, see Supplemental Material, Table S4. 
*SNPs, rs2325934 and rs17284098, identified in the present report to interact with PM10 exposure on decline in FEF25–75%.
Forward strand 1.17 Mb CDH13: ENST00000566620 transcript length: 4,0001 bp, translation length: 713 residues






































































































78 volume 123 | number 1 | January 2015 • Environmental Health Perspectives
that cadherin 13 was required to mediate the 
protective effect of adiponectin on allergen-
induced airway inflammation (Williams et al. 
2012). In human studies, CDH13 has been 
consistently identified by GWAS as a deter-
minant of circulating adiponectin (Dastani 
et al. 2012), and serum adiponectin concen-
trations were positively associated with peak 
lung function in a prospective study of young 
healthy adults (Thyagarajan et al. 2010).
Adiponectin is secreted primarily by visceral 
adipocytes (Arita et al. 1999). Body composi-
tion and especially visceral adiposity have been 
associated with lower lung function and accel-
erated age-related decline (Rossi et al. 2011; 
Wehrmeister et al. 2012). We were among the 
first to report evidence of a modifying effect of 
obesity on the association of air pollution with 
lung function decline (Schikowski et al. 2013).
A strength of the current analysis is the 
detailed characterization of the cohort partici-
pants, as well as the cohort’s prospective design 
to specifically investigate longitudinally air 
pollution health effects. The fact that discovery 
and replication samples derive from the 
SAPALDIA cohort pool is a strength of this 
analysis. Both samples were recruited at the 
same time by the same field workers using the 
same standardized procedures. Nonetheless, 
larger studies in independent populations with 
different environmental and ethnic charac-
teristics are needed to confirm the observed 
inter actions between CDH13 genetic variants 
and PM10. Genome-wide inter actions between 
environmental exposures and genetic variants 
on complex health phenotypes form an active 
field of investigation, and novel methodologies 
are being developed to address analytical chal-
lenges associated with this research (Ege et al. 
2011; Gauderman et al. 2013; Hutter et al. 
2013; Sohns et al. 2013). Recently, a genome-
wide analysis investigating genetic modifiers 
of associations between occupational expo-
sures and lung function combined the GWIS 
approach with an in silico pathway analysis that 
indicated the involvement of inflammatory 
pathways (Liao et al. 2013).
There are several limitations, in addition 
to low power, in the present study. First, less 
than half of all baseline cohort participants 
were included in the analysis, leaving room for 
potential bias. Second, given the pleiotropic 
health outcomes associated with CDH13 in 
previous GWAS, it is conceivable that modi-
fication of the air pollution–lung function 
association reflected an underlying suscepti-
bility caused by health conditions associated 
with CDH13 genotypes, such as cardiovascular 
phenotypes, rather than a causal inter action 
between the genotypes and PM10. In the 
absence of measured adiponectin levels we 
cannot verify whether the apparent modifying 
effect of CDH13 is mediated through this 
adipokine. Genetic variants of the adiponectin 
precursor protein encoded by the gene 
ADIPOQ were by definition included in our 
GWIS analysis. We looked up the inter actions 
between PM10 exposure and nine haplotype 
tagging variants of the ADIPOQ gene (Peters 
et al. 2013). None of these SNPs showed signif-
icant inter actions (pint = 0.07 to pint = 0.95; 
for regional association plot of the ADIPOQ 
locus, see Supplemental Material, Figure S3). 
The CDH13 SNPs associated with adiponectin 
circulating level (rs3865188, rs4783244, 
rs12051272) (Chung et al. 2011; Dastani et al. 
2012; Jee et al. 2010; Morisaki et al. 2012; Wu 
et al. 2010) were in very low LD (r2 < 0.1) and 
thus contained in a different haplotype block 
than the CDH13 SNPs interacting with PM10 
(Figure 3). Nevertheless, rs3865188 previously 
associated with adiponectin (Jee et al. 2010; 
Wu et al. 2010) interacted with PM10 at a 
nominal p-value of 0.06 in our study.
Because we focused a priori on FEF25–75% 
decline for this GWIS, we did not evaluate 
inter actions between PM10 and previously 
identified GWAS signals on associations with 
FEV1 or FVC (Artigas et al. 2011; Hancock 
et al. 2010, 2012; Obeidat et al. 2011; Repapi 
et al. 2010; Wilk et al. 2009). Another limita-
tion is that although asthmatic subjects appear 
to be more vulnerable to effects of air pollu-
tion exposure (Trasande and Thurston 2005), 
we restricted the current analyses to nonasth-
matics. This sample restriction was based on 
our previous finding of an extended heteroge-
neity in the GWAS-identified determinants of 
lung function decline of healthy individuals 
compared with asthmatics (Imboden et al. 
2012). Finally, comparing genotype-stratified 
analyses in the SAPALDIA cohort, the size 
of effect modification by the CDH13 SNPs 
reported here on the PM10–FEF25–75% asso-
ciation is substantially smaller than the size of 
effect modification by SERPINA1 genotypes 
(underlying intermediate alpha 1 antitrypsin 
deficiency) on the association of FEF25–75% 
decline with occupational exposure to vapors, 
dusts, gases, and fumes (Mehta et al. 2012). 
This is not unexpected for genome-wide 
signals of unknown functional relevance. 
The limitation of genome-wide signals with 
regard to clinical utility is a well-known 
problem of GWAS.
In conclusion, the mechanistic link 
between adiponectin (its modulating action on 
inflammatory processes systemically and locally 
in the lung) and cadherin 13 (its sequestering 
action on circulating adiponectin levels) make 
our GWIS finding, CDH13, a biologically 
plausible candidate gene for modifying the air 
pollution exposure effect. Follow-up studies 
need to confirm the observed inter action with 
CDH13 SNPs and must assess whether the 
finding is related to recent evidence on the 
modifying effect of obesity on the association 
between PM10 and decline in lung function.
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